Kevin M Fussell, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 326 Santa Fe Dr Ste 100, Encinitas, CA 92024 Phone: 760-230-8994 |
Michelle Zhang, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-633-6507 |
Dr. Patricia Elisabeth Hogan, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-633-6507 |
Dr. Andrew Y Hsing, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Santa Fe Dr Ste 107-c, Encinitas, CA 92024 Phone: 760-230-8994 |
News Archive
More than 300 million play soccer across the globe and while the game is one of fast footwork, two organizations are trying to make sure these athletes stay on their feet. F-d-ration Internationale de Football Association (FIFA) and International Cartilage Repair Society (ICRS) have teamed up on a special supplement of Cartilage (published by SAGE) that examines the effects of articular cartilage injury and degeneration in soccer players.
New research from Boston Children's Hospital could potentially change how doctors approach two blinding diseases: 'Wet' age-related macular degeneration (AMD), the leading cause of blindness in the elderly, and macular telangiectasia (MacTel).
Lawmakers charged with finalizing the Consumer Product Safety Commission Reform Act agreed yesterday to include a provision that will ban phthalates from children's toys and childcare articles. The legislative action validates the concerns of scientists and parents who have been urging a ban, and will bring federal regulation in line with several states and leading retailers that have already taken action to remove phthalates from toys.
As if women are not confused enough about the pros and cons of hormone replacement therapy (HRT), an international group of experts now say safety issues regarding HRT have been "over hyped".
Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRAâ„¢ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.
› Verified 3 days ago